|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar
|
|
2
|
Rini BI, Campbell SC and Escudier B: Renal
cell carcinoma. Lancet. 373:1119–1132. 2009. View Article : Google Scholar
|
|
3
|
Delahunt B, Bethwaite PB and Nacey JN:
Outcome prediction for renal cell carcinoma: Evaluation of
prognostic factors for tumors divided according to histological
subtype. Pathology. 39:459–465. 2007. View Article : Google Scholar
|
|
4
|
Lin YF, Chou JL, Chang JS, Chiu IJ, Chiu
HW and Lin YF: Dysregulation of the miR-25-IMPA2 axis promotes
metastatic progression in clear cell renal cell carcinoma.
EBioMedicine. 45:220–230. 2019. View Article : Google Scholar :
|
|
5
|
Afriansyah A, Hamid AR, Mochtar CA and
Umbas R: Targeted therapy for metastatic renal cell carcinoma. Acta
Med Indones. 48:335–347. 2016.
|
|
6
|
Husnjak K and Dikic I: Ubiquitin-binding
proteins: Decoders of ubiquitin-mediated cellular functions. Annu
Rev Biochem. 81:291–322. 2012. View Article : Google Scholar
|
|
7
|
Harada K, Kato M and Nakamura N:
USP19-mediated deubiquitination facilitates the stabilization of
HRD1 ubiquitin ligase. Int J Mol Sci. 17(pii): E18292016.
View Article : Google Scholar
|
|
8
|
Fraile JM, Quesada V, Rodríguez D, Freije
JM and López-Otín C: Deubiquitinases in cancer: New functions and
therapeutic options. Oncogene. 31:2373–2388. 2012. View Article : Google Scholar
|
|
9
|
Hu M, Li P, Li M, Li W, Yao T, Wu JW, Gu
W, Cohen RE and Shi Y: Crystal structure of a UBP-family
deubiquitinating enzyme in isolation and in complex with ubiquitin
aldehyde. Cell. 111:1041–1054. 2002. View Article : Google Scholar
|
|
10
|
Hassink GC, Zhao B, Sompallae R, Altun M,
Gastaldello S, Zinin NV, Masucci MG and Lindsten K: The ER-resident
ubiquitin-specific protease 19 participates in the UPR and rescues
ERAD substrates. EMBO Rep. 10:755–761. 2009. View Article : Google Scholar :
|
|
11
|
Jin S, Tian S, Chen Y, Zhang C, Xie W, Xia
X, Cui J and Wang RF: USP19 modulates autophagy and antiviral
immune responses by deubiquitinating Beclin-1. EMBO J. 35:866–880.
2016. View Article : Google Scholar :
|
|
12
|
Gierisch ME, Pedot G, Walser F,
Lopez-Garcia LA, Jaaks P, Niggli FK and Schäfer BW: USP19
deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth. Sci Rep.
9:9512019. View Article : Google Scholar :
|
|
13
|
Shahriyari L, Abdel-Rahman M and Cebulla
C: BAP1 expression is prognostic in breast and uveal melanoma but
not colon cancer and is highly positively correlated with RBM15B
and USP19. PLoS One. 14:e02115072019. View Article : Google Scholar :
|
|
14
|
Eikrem O, Beisland C, Hjelle K, Flatberg
A, Scherer A, Landolt L, Skogstrand T, Leh S, Beisvag V and Marti
HP: Transcriptome sequencing (RNAseq) enables utilization of
Formalin-fixed, paraffin-embedded biopsies with clear cell renal
cell carcinoma for exploration of disease biology and biomarker
development. PLoS One. 11:e01497432016. View Article : Google Scholar :
|
|
15
|
Yao X, Tan J, Lim KJ, Koh J, Ooi WF, Li Z,
Huang D, Xing M, Chan YS, Qu JZ, et al: VHL deficiency drives
enhancer activation of oncogenes in clear cell renal cell
carcinoma. Cancer Discov. 7:1284–1305. 2017. View Article : Google Scholar
|
|
16
|
R Core Team: R: A language and environment
for statistical computing. R Foundation for Statistical Computing;
Vienna: 2104
|
|
17
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar :
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals, . Guide for the Care and Use of Laboratory Animals, 8th
edition. National Academies Press (US); Washington, DC: 2011
|
|
20
|
Macè A, Kutalik Z and Valsesia A: Copy
number variation. Methods Mol Biol. 1793:231–258. 2018. View Article : Google Scholar
|
|
21
|
Zińczuk J, Zaręba K, Guzińska-Ustymowicz
K1, Kędra B Kemona A and Pryczynicz A: Expression of chosen cell
cycle and proliferation markers in pancreatic intraepithelial
neoplasia. Prz Gastroenterol. 13:118–126. 2018.
|
|
22
|
Sarsik B, Doganavsargil B, Simsir A,
Yazici A, Pehlivanoglu B, Cal C and Sen S: P21 and p27
immunoexpression in upper urinary tract urothelial carcinomas.
Pathol Oncol Res. 22:839–845. 2016. View Article : Google Scholar
|
|
23
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar
|
|
24
|
Björklund M and Koivunen E:
Gelatinase-mediated migration and invasion of cancer cells. Biochim
Biophys Acta. 1755:37–69. 2005.
|
|
25
|
Wang D, Wang D, Wang N, Long Z and Ren X:
Long Non-coding RNA BANCR promotes endometrial cancer cell
proliferation and invasion by regulating MMP2 and MMP1 via ERK/MAPK
signaling pathway. Cell Physiol Biochem. 40:644–656. 2016.
View Article : Google Scholar
|
|
26
|
Tian XQ, Guo FF, Sun DF, Wang YC, Yang L,
Chen SL, Hong J and Fang JY: Downregulation of ZNF278 arrests the
cell cycle and decreases the proliferation of colorectal cancer
cells via inhibition of the ERK/MAPK pathway. Oncol Rep.
38:3685–3692. 2017.
|
|
27
|
He W, Ju D, Jie Z, Zhang A, Xing X and
Yang Q: Aberrant CpG-methylation affects genes expression
predicting survival in lung adenocarcinoma. Cancer Med.
7:5716–5726. 2018. View Article : Google Scholar :
|
|
28
|
Schuijers J, Manteiga JC, Weintraub AS,
Day DS, Zamudio AV, Hnisz D, Lee TI and Young RA: Transcriptional
dysregulation of MYC reveals common enhancer-docking mechanism.
Cell Rep. 23:349–360. 2018. View Article : Google Scholar :
|
|
29
|
Gu X, Coates PJ, Boldrup L, Wang L, Krejci
A, Hupp T, Fahraeus R, Norberg-Spaak L, Sgaramella N, Wilms T and
Nylander K: Copy number variation: A prognostic marker for young
patients with squamous cell carcinoma of the oral tongue. J Oral
Pathol Med. 48:24–30. 2019. View Article : Google Scholar
|
|
30
|
Wee Y, Wang T, Liu Y, Li X and Zhao M: A
pan-cancer study of copy number gain and up-regulation in human
oncogenes. Life Sci. 211:206–214. 2018. View Article : Google Scholar
|
|
31
|
Wang L, Zhao H, Xu Y, Li J, Deng C, Deng
Y, Bai J, Li X, Xiao Y and Zhang Y: Systematic identification of
lincRNA-based prognostic biomarkers by integrating lincRNA
expression and copy number variation in lung adenocarcinoma. Int J
Cancer. 144:1723–1734. 2019. View Article : Google Scholar
|
|
32
|
Duan X, Jiang B, Yang J, Zhou L, Tian B
and Mao X: FOXP3 inhibits MYC expression via regulating miR-198 and
influences cell viability, proliferation and cell apoptosis in
HepG2. Cancer Med. 7:6182–6192. 2018. View Article : Google Scholar :
|
|
33
|
He J, Yu L, Wang CM and Zhou XF: MiR-1275
promotes non-small cell lung cancer cell proliferation and
metastasis by regulating LZTS3 expression. Eur Rev Med Pharmacol
Sci. 22:2680–2687. 2018.
|
|
34
|
Chen Y, Zhang L, Liu L, Sun S, Zhao X,
Wang Y, Zhang Y, Du J and Gu L: Rasip1 is a RUNX1 target gene and
promotes migration of NSCLC cells. Cancer Manag Res. 10:4537–4552.
2018. View Article : Google Scholar :
|
|
35
|
Wang Y, Zheng C, Li T, Zhang R, Wang Y,
Zhang J, He Q, Sun Z and Wang X: Long noncoding RNA Z38 promotes
cell proliferation and metastasis and inhibits cell apoptosis in
human gastric cancer. Oncol Lett. 16:6051–6058. 2018.
|
|
36
|
Lu Y, Bedard N, Chevalier S and Wing SS:
Identification of distinctive patterns of USP19-mediated growth
regulation in normal and malignant cells. PLoS One. 6:e159362011.
View Article : Google Scholar :
|
|
37
|
Bao H, Guo CG, Qiu PC, Zhang XL, Dong Q
and Wang YK: Long non-coding RNA Igf2as controls hepatocellular
carcinoma progression through the ERK/MAPK signaling pathway. Oncol
Lett. 14:2831–2837. 2017. View Article : Google Scholar :
|
|
38
|
Li B, Liu YH, Sun AG, Huan LC, Li HD and
Liu DM: MiR-130b functions as a tumor promoter in glioma via
regulation of ERK/MAPK pathway. Eur Rev Med Pharmacol Sci.
21:2840–2846. 2017.
|
|
39
|
Wu M, Tu HQ, Chang Y, Tan B, Wang G, Zhou
J, Wang L, Mu R and Zhang WN: USP19 deubiquitinates HDAC1/2 to
regulate DNA damage repair and control chromosomal stability.
Oncotarget. 8:2197–2208. 2017.
|
|
40
|
Liu Q, Zhao S, Su PF and Yu S: Gene and
isoform expression signatures associated with tumor stage in kidney
renal clear cell carcinoma. BMC Syst Biol. 7 (Suppl 5):S72013.
View Article : Google Scholar
|
